Your browser doesn't support javascript.
loading
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
Landovitz, Raphael J; Li, Sue; Grinsztejn, Beatriz; Dawood, Halima; Liu, Albert Y; Magnus, Manya; Hosseinipour, Mina C; Panchia, Ravindre; Cottle, Leslie; Chau, Gordon; Richardson, Paul; Marzinke, Mark A; Hendrix, Craig W; Eshleman, Susan H; Zhang, Yinfeng; Tolley, Elizabeth; Sugarman, Jeremy; Kofron, Ryan; Adeyeye, Adeola; Burns, David; Rinehart, Alex R; Margolis, David; Spreen, William R; Cohen, Myron S; McCauley, Marybeth; Eron, Joseph J.
Afiliación
  • Landovitz RJ; UCLA Center for Clinical AIDS Research and Education, Los Angeles, California, United States of America.
  • Li S; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Dawood H; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu Natal, Durban, South Africa.
  • Liu AY; Bridge HIV, Population Health Division, San Francisco Department of Health, San Francisco, California, United States of America.
  • Magnus M; Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, United States of America.
  • Hosseinipour MC; UNC Project-Malawi, Lilongwe, Malawi.
  • Panchia R; Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa.
  • Cottle L; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Chau G; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Richardson P; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Marzinke MA; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Hendrix CW; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Eshleman SH; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Zhang Y; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Tolley E; FHI360, Durham, North Carolina, United States of America.
  • Sugarman J; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Kofron R; Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Adeyeye A; UCLA Center for Clinical AIDS Research and Education, Los Angeles, California, United States of America.
  • Burns D; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Rinehart AR; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Margolis D; ViiV Healthcare, Durham, North Carolina, United States of America.
  • Spreen WR; ViiV Healthcare, Durham, North Carolina, United States of America.
  • Cohen MS; ViiV Healthcare, Durham, North Carolina, United States of America.
  • McCauley M; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Eron JJ; FHI360, Durham, North Carolina, United States of America.
PLoS Med ; 15(11): e1002690, 2018 11.
Article en En | MEDLINE | ID: mdl-30408115
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles Asunto principal: Piridonas / Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Africa / America do norte / America do sul / Brasil Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles Asunto principal: Piridonas / Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Africa / America do norte / America do sul / Brasil Idioma: En Revista: PLoS Med Asunto de la revista: MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos